These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 14559885)

  • 1. Predictors of occult metastasis in clinical stage I nonseminoma: a systematic review.
    Vergouwe Y; Steyerberg EW; Eijkemans MJ; Albers P; Habbema JD
    J Clin Oncol; 2003 Nov; 21(22):4092-9. PubMed ID: 14559885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical expression of Ki-67 to predict lymph node involvement in clinical stage I nonseminomatous germ cell tumors.
    Heidenreich A; Schenkmann NS; Sesterhenn IA; Mostofi FK; McCarthy WF; Heidenreich B; Moul JW
    J Urol; 1997 Aug; 158(2):620-5. PubMed ID: 9224380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of systemic metastases in clinical stage I nonseminoma germ cell testis tumor managed by retroperitoneal lymph node dissection.
    Hermans BP; Sweeney CJ; Foster RS; Einhorn LE; Donohue JP
    J Urol; 2000 Jun; 163(6):1721-4. PubMed ID: 10799168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MIB-1 immunohistochemistry in clinical stage I nonseminomatous testicular germ cell tumors predicts patients at low risk for metastasis.
    Albers P; Bierhoff E; Neu D; Fimmers R; Wernert N; Müller SC
    Cancer; 1997 May; 79(9):1710-6. PubMed ID: 9128986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis.
    Heidenreich A; Sesterhenn IA; Mostofi FK; Moul JW
    Cancer; 1998 Sep; 83(5):1002-11. PubMed ID: 9731905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical assessment of tumor proliferation and volume of embryonal carcinoma identify patients with clinical stage A nonseminomatous testicular germ cell tumor at low risk for occult metastasis.
    Albers P; Miller GA; Orazi A; Ulbright TM; Albers J; Donohue JP; Foster RS
    Cancer; 1995 Feb; 75(3):844-50. PubMed ID: 7828136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simple model for predicting nodal metastasis in patients with clinical stage I nonseminomatous germ cell testicular tumors undergoing retroperitoneal lymph node dissection only.
    Nicolai N; Miceli R; Artusi R; Piva L; Pizzocaro G; Salvioni R
    J Urol; 2004 Jan; 171(1):172-6. PubMed ID: 14665870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percentage of embryonal carcinoma and of vascular invasion predicts pathological stage in clinical stage I nonseminomatous testicular cancer.
    Moul JW; McCarthy WF; Fernandez EB; Sesterhenn IA
    Cancer Res; 1994 Jan; 54(2):362-4. PubMed ID: 8275469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph Node Yield in Primary Retroperitoneal Lymph Node Dissection for Nonseminoma Germ Cell Tumors.
    Nayan M; Jewett MA; Sweet J; Anson-Cartwright L; Bedard PL; Moore M; Chung P; Warde P; Hamilton RJ
    J Urol; 2015 Aug; 194(2):386-91. PubMed ID: 25823792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors in low-stage nonseminomatous testicular cancer.
    Moul JW; Heidenreich A
    Oncology (Williston Park); 1996 Sep; 10(9):1359-68, 1374; discussion 1377-8. PubMed ID: 8882926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group.
    Heidenreich A; Albers P; Hartmann M; Kliesch S; Kohrmann KU; Krege S; Lossin P; Weissbach L;
    J Urol; 2003 May; 169(5):1710-4. PubMed ID: 12686815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of positive retroperitoneal lymph nodes in patients with high risk testicular cancer.
    Williams SB; Kacker R; Winston D; Bahnson E; Steele GS; Richie JP
    J Urol; 2011 Dec; 186(6):2245-8. PubMed ID: 22014805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk stratification of pubertal children and postpubertal adolescents with clinical stage I testicular nonseminomatous germ cell tumors.
    Cost NG; Lubahn JD; Adibi M; Romman A; Wickiser JE; Raj GV; Sagalowsky AI; Margulis V
    J Urol; 2014 May; 191(5 Suppl):1485-90. PubMed ID: 24679874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphovascular invasion and presence of embryonal carcinoma as risk factors for occult metastatic disease in clinical stage I nonseminomatous germ cell tumour: a systematic review and meta-analysis.
    Blok JM; Pluim I; Daugaard G; Wagner T; Jóźwiak K; Wilthagen EA; Looijenga LHJ; Meijer RP; Bosch JLHR; Horenblas S
    BJU Int; 2020 Mar; 125(3):355-368. PubMed ID: 31797520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Teratoma in primary testis tumor reduces complete response rates in the retroperitoneum after primary chemotherapy. The case for primary retroperitoneal lymph node dissection of stage IIb germ cell tumors with teratomatous elements.
    Rabbani F; Gleave ME; Coppin CM; Murray N; Sullivan LD
    Cancer; 1996 Aug; 78(3):480-6. PubMed ID: 8697394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New prognostic factors for stage I testicular cancer: but will they make it to broadway?
    Raghavan D
    J Clin Oncol; 2003 Nov; 21(22):4075-6. PubMed ID: 14559887
    [No Abstract]   [Full Text] [Related]  

  • 17. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
    Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
    Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concordance and prediction ability of original and reviewed vascular invasion and other prognostic parameters of clinical stage I nonseminomatous germ cell testicular tumors after retroperitoneal lymph node dissection.
    Nicolai N; Colecchia M; Biasoni D; Catanzaro M; Stagni S; Torelli T; Necchi A; Piva L; Milani A; Salvioni R
    J Urol; 2011 Oct; 186(4):1298-302. PubMed ID: 21849196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. alpha-Catenin expression pattern and DNA image-analysis cytometry have no additional value over primary histology in clinical stage I nonseminomatous testicular cancer.
    Spermon JR; De Wilde PC; Hanselaar AG; Schaafsma HE; Ruijter TE; Witjes JA; Van Moorselaar RJ
    BJU Int; 2002 Feb; 89(3):278-84. PubMed ID: 11856111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Testicular tumor--retroperitoneal lymph node excision successful in patients with stage I nonseminomatous cancer with or without vascular invasion].
    Brudermanns B
    Aktuelle Urol; 2007 Jan; 38(1):1-2. PubMed ID: 17290323
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.